BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 9763348)

  • 1. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies.
    Haas FJ; van Sterkenburg-Kamp BM; Scheepers HA
    Semin Thromb Hemost; 1998; 24(4):355-62. PubMed ID: 9763352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital protein S deficiencies; diagnostic difficulties].
    Guermazi S; Conard J
    Pathol Biol (Paris); 2009 Sep; 57(6):483-7. PubMed ID: 18583066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
    Schöni R; Quehenberger P; Wu JR; Wilmer M
    Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
    Greiner K; Hafner G; Prellwitz W; Pfeiffer N
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
    Toulon P
    Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro CR global: an effective screening test for thrombophilia.
    Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
    Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.